The company aims to advise pharmaceutical companies, academic institutions (universities, etc.) and service providers in all matters related to the discovery, development, approval and manufacture of radiopharmaceuticals for use in animals and humans. The company may establish branches and subsidiaries in Switzerland and abroad and participate in other companies in Switzerland and abroad, as well as conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, sell and manage real estate in Switzerland and abroad. It may also provide financing for its own account or for the account of third parties, as well as provide guarantees and sureties for subsidiaries and third parties.